Şunu aradınız:: omalizumabas (Litvanca - İngilizce)

omalizumabas
omalizumab

omalizumabas 300 mg
omalizumab 300 mg

veiklioji medžiaga yra omalizumabas.
the active substance is omalizumab.

-veiklioji medziaga yra omalizumabas.
-the active substance is omalizumab.

savaitė skiriamas omalizumabas arba placebas
week omalizumab or placebo administered

xolair 75 mg injekcinis tirpalas omalizumabas
xolair 75 mg solution for injection omalizumab

xolair veiklioji medziaga omalizumabas yra monokloninis antiknas.
the active substance in xolair, omalizumab, is a monoclonal antibody.

xolair 150 mg injekcinis tirpalas omalizumabas vartoti s. c.
xolair 150 mg solution for injection omalizumab sc use

xolair 75 mg injekcinis tirpalas xolair 150 mg injekcinis tirpalas omalizumabas
xolair 75 mg solution for injection xolair 150 mg solution for injection omalizumab

omalizumabas astmos pamjim dazn sumazino 19% (p = 0, 153) .
omalizumab reduced the rate of asthma exacerbations by 19% (p = 0.153) .

prisijungęs prie ige, omalizumabas „išvalo“ kraujyje laisvai cirkuliuojantį ige.
by attaching to ige, omalizumab ‘mops up’ the free ige circulating in the blood.

omalizumabas astmos paūmėjimų dažnį sumažino 19 % (p = 0,153).
omalizumab reduced the rate of asthma exacerbations by 19% (p = 0.153).

buteliuke yra 150 mg omalizumabo.
one vial contains 150 mg omalizumab.